These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8918687)

  • 1. Effects of cytokines and glucocorticoids on endogenous class II MHC antigen expression by activated rat CD4+ T cells. Mature CD4+ CD8- thymocytes are phenotypically heterogeneous on activation.
    Seddon B; Mason D
    Int Immunol; 1996 Aug; 8(8):1185-93. PubMed ID: 8918687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of intrathymic CD4-Ia interactions on immature CD4+CD8+ thymocytes results in diminished TCR expression on mature CD8+ T cell progeny.
    Roberts JL; Sharrow SO; Singer A
    Cell Immunol; 1995 Mar; 161(1):22-7. PubMed ID: 7867081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive CD8 expression allows inefficient maturation of CD4+ helper T cells in class II major histocompatibility complex mutant mice.
    Robey E; Itano A; Fanslow WC; Fowlkes BJ
    J Exp Med; 1994 Jun; 179(6):1997-2004. PubMed ID: 7515104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signals.
    Mannie MD; Dawkins JG; Walker MR; Clayson BA; Patel DM
    Cell Immunol; 2004 Jul; 230(1):33-43. PubMed ID: 15541717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro.
    Park JH; Hanke T; Hünig T
    Eur J Immunol; 1996 Oct; 26(10):2371-5. PubMed ID: 8898947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.
    Kaye J; Hsu ML; Sauron ME; Jameson SC; Gascoigne NR; Hedrick SM
    Nature; 1989 Oct; 341(6244):746-9. PubMed ID: 2571940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class II molecules are required for initiation of positive selection but not during terminal differentiation of human CD4 single positive thymocytes.
    Vanhecke D; Verhasselt B; De Smedt M; De Paepe B; Leclercq G; Plum J; Vandekerckhove B
    J Immunol; 1997 Apr; 158(8):3730-7. PubMed ID: 9103437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells.
    Brocker T
    J Exp Med; 1997 Oct; 186(8):1223-32. PubMed ID: 9334361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.
    Crompton T; Lees RK; Pircher H; MacDonald HR
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8982-6. PubMed ID: 8415641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of major histocompatibility complex class II but not of CD8 molecules by lectin-stimulated peripheral CD4+ T cells in LEC mutant rats.
    Sakai T; Agui T; Matsumoto K
    Cell Immunol; 1994 Oct; 158(2):414-22. PubMed ID: 7923392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of T cell receptor expression in immature CD4+CD8+ thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules.
    Wiest DL; Yuan L; Jefferson J; Benveniste P; Tsokos M; Klausner RD; Glimcher LH; Samelson LE; Singer A
    J Exp Med; 1993 Nov; 178(5):1701-12. PubMed ID: 8228817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.
    Marusić-Galesić S; Walden P
    Immunology; 1995 Jul; 85(3):442-6. PubMed ID: 7558133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction by elimination of subsets of self-reactive thymocytes.
    Sponaas AM; Tomlinson PD; Schulz R; Antoniou J; Ize-Iyamu P; Schmitt-Verhulst AM; Mellor AL
    Int Immunol; 1994 Oct; 6(10):1593-604. PubMed ID: 7826949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell development in a major histocompatibility complex class II-deficient patient.
    van Eggermond MC; Rijkers GT; Kuis W; Zegers BJ; van den Elsen PJ
    Eur J Immunol; 1993 Oct; 23(10):2585-91. PubMed ID: 8405058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage.
    Volkmann A; Barthlott T; Weiss S; Frank R; Stockinger B
    J Exp Med; 1998 Sep; 188(6):1083-9. PubMed ID: 9743527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.